Perception of the COVID-19 Pandemic Among Patients With Inflammatory Bowel Disease in the Time of Telemedicine: Cross-Sectional Questionnaire Study

被引:16
作者
Zingone, Fabiana [1 ]
Siniscalchi, Monica [2 ]
Savarino, Edoardo Vincenzo [1 ]
Barberio, Brigida [1 ]
Cingolani, Linda [1 ]
D'Inca, Renata [1 ]
De Filippo, Francesca Romana [2 ]
Camera, Silvia [2 ]
Ciacci, Carolina [2 ]
机构
[1] Univ Padua, Inflammatory Bowel Dis Ctr, Dept Surg Oncol & Gastroenterol, Padua, Italy
[2] Univ Salerno, Univ Hosp San Giovanni Dio & Ruggi dAragona, Inflammatory Bowel Dis Ctr, Dept Med Surg Dent Scuola Med Salernitana, Via San Leonardo 1, I-84131 Salerno, Italy
关键词
COVID-19; IBD; ulcerative colitis; Crohn disease; telemedicine; biologic agents; perception; survey; OPPORTUNISTIC INFECTIONS; CROHNS-DISEASE; RISK;
D O I
10.2196/19574
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: After the COVID-19 outbreak, the Italian Government stopped most regular health care activity. As a result, patients with inflammatory bowel disease (IBD) had limited access to outpatient clinics and hospitals. Objective: This study aimed to analyze the perception of the COVID-19 emergency among patients with IBD during the early weeks of the lockdown. Methods: We invited adult patients with IBD from the University of Salerno (Campania, South Italy) and the University of Padua (Veneto, North Italy) by email to answer an ad hoc anonymous survey about COVID-19. We also collected data on demographic and disease characteristics. Results: In total, 167 patients with IBD from Padua and 83 patients from Salerno answered the survey (age: mean 39.7 years, SD 13.9 years; female: n=116, 46.4%). We found that patients with IBD were particularly worried about the COVID-19 pandemic (enough: 77/250, 30.8%; much/very much: 140/250, 56.0%), as they felt more vulnerable to COVID-19 due to their condition (enough: 70/250, 28.0%; much/very much: 109/250, 43.6%). Patients with IBD from the red zone of Veneto were more worried than patients from Campania (P=.001), and men felt more susceptible to the virus than women (P=.05). Additionally, remote medicine was appreciated more by younger patients than older patients (P=.04). Conclusions: The results of our survey demonstrate that the lockdown had a significant impact on the psychological aspects of patients with IBD and suggest the need for increasing communication with patients with IBD (eg, through telemedicine) to ensure patients receive adequate health care, correct information, and proper psychological support.
引用
收藏
页数:9
相关论文
共 35 条
[31]   Inflammatory Bowel Disease (IBD) pharmacotherapy and the risk of serious infection: a systematic review and network meta-analysis [J].
Wheat, Chelle L. ;
Ko, Cynthia W. ;
Clark-Snustad, Kindra ;
Grembowski, David ;
Thornton, Timothy A. ;
Devine, Beth .
BMC GASTROENTEROLOGY, 2017, 17
[32]   Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study [J].
Yang, Xiaobo ;
Yu, Yuan ;
Xu, Jiqian ;
Shu, Huaqing ;
Xia, Jia'an ;
Liu, Hong ;
Wu, Yongran ;
Zhang, Lu ;
Yu, Zhui ;
Fang, Minghao ;
Yu, Ting ;
Wang, Yaxin ;
Pan, Shangwen ;
Zou, Xiaojing ;
Yuan, Shiying ;
Shang, You .
LANCET RESPIRATORY MEDICINE, 2020, 8 (05) :475-481
[33]   Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [J].
Zhou, Fei ;
Yu, Ting ;
Du, Ronghui ;
Fan, Guohui ;
Liu, Ying ;
Liu, Zhibo ;
Xiang, Jie ;
Wang, Yeming ;
Song, Bin ;
Gu, Xiaoying ;
Guan, Lulu ;
Wei, Yuan ;
Li, Hui ;
Wu, Xudong ;
Xu, Jiuyang ;
Tu, Shengjin ;
Zhang, Yi ;
Chen, Hua ;
Cao, Bin .
LANCET, 2020, 395 (10229) :1054-1062
[34]   Starting a Biologic Therapy in IBD Patients Amid COVID-19: Hold, Careful Monitoring, or Testing? [J].
Zingone, Fabiana ;
Buda, Andrea ;
Savarino, Edoardo Vincenzo .
JOURNAL OF CROHNS & COLITIS, 2020, 14 (12) :1785-1785
[35]   Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak [J].
Zingone, Fabiana ;
Savarino, Edoardo Vincenzo .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (06) :525-525